Harrow Health Inc. (HROW)
Harrow Health Statistics
Share Statistics
Harrow Health has 35.61M shares outstanding. The number of shares has increased by 0.71% in one year.
| Shares Outstanding | 35.61M |
| Shares Change (YoY) | 0.71% |
| Shares Change (QoQ) | 0.37% |
| Owned by Institutions (%) | 58.34% |
| Shares Floating | 30.76M |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 3.03M, so 8.51% of the outstanding shares have been sold short.
| Short Interest | 3.03M |
| Short % of Shares Out | 8.51% |
| Short % of Float | 9.85% |
| Short Ratio (days to cover) | 9.13 |
Valuation Ratios
The PE ratio is -14.96 and the forward PE ratio is 36.95. Harrow Health's PEG ratio is -0.32.
| PE Ratio | -14.96 |
| Forward PE | 36.95 |
| PS Ratio | 2.81 |
| Forward PS | 1.4 |
| PB Ratio | 5.16 |
| P/FCF Ratio | -2.46 |
| PEG Ratio | -0.32 |
Enterprise Valuation
Harrow Health Inc. has an Enterprise Value (EV) of 481.72M.
| EV / Earnings | -19.73 |
| EV / Sales | 3.7 |
| EV / EBITDA | 49.54 |
| EV / EBIT | 1117.69 |
| EV / FCF | -3.24 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 2.69.
| Current Ratio | 2.83 |
| Quick Ratio | 2.61 |
| Debt / Equity | 2.69 |
| Total Debt / Capitalization | 72.91 |
| Cash Flow / Debt | 0.02 |
| Interest Coverage | 0.02 |
Financial Efficiency
Return on equity (ROE) is -0.34% and return on capital (ROIC) is 0.17%.
| Return on Equity (ROE) | -0.34% |
| Return on Assets (ROA) | -0.08% |
| Return on Capital (ROIC) | 0.17% |
| Revenue Per Employee | $413,311.11 |
| Profits Per Employee | $-77,495.24 |
| Employee Count | 315 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.65 |
Taxes
| Income Tax | 701K |
| Effective Tax Rate | -0.03 |
Stock Price Statistics
The stock price has increased by 116.97% in the last 52 weeks. The beta is 0.69, so Harrow Health's price volatility has been higher than the market average.
| Beta | 0.69 |
| 52-Week Price Change | 116.97% |
| 50-Day Moving Average | 29.26 |
| 200-Day Moving Average | 35.01 |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (20 Days) | 426.27K |
Income Statement
In the last 12 months, Harrow Health had revenue of 130.19M and earned -24.41M in profits. Earnings per share was -0.75.
| Revenue | 130.19M |
| Gross Profit | 90.55M |
| Operating Income | 431K |
| Net Income | -24.41M |
| EBITDA | 9.72M |
| EBIT | 431K |
| Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 74.08M in cash and 190.5M in debt, giving a net cash position of -116.42M.
| Cash & Cash Equivalents | 74.08M |
| Total Debt | 190.5M |
| Net Cash | -116.42M |
| Retained Earnings | -133.9M |
| Total Assets | 351.54M |
| Working Capital | 52.06M |
Cash Flow
In the last 12 months, operating cash flow was 3.84M and capital expenditures -152.55M, giving a free cash flow of -148.71M.
| Operating Cash Flow | 3.84M |
| Capital Expenditures | -152.55M |
| Free Cash Flow | -148.71M |
| FCF Per Share | -4.56 |
Margins
Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.
| Gross Margin | 69.55% |
| Operating Margin | 0.33% |
| Pretax Margin | -18.21% |
| Profit Margin | -18.75% |
| EBITDA Margin | 7.47% |
| EBIT Margin | 0.33% |
| FCF Margin | -114.23% |
Dividends & Yields
HROW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.72% |
| FCF Yield | -15.12% |
Analyst Forecast
The average price target for HROW is $56, which is 102.8% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56 |
| Price Target Difference | 102.8% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Feb 8, 2013. It was a backward split with a ratio of 1:5.
| Last Split Date | Feb 8, 2013 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | 2.05 |
| Piotroski F-Score | 4 |